Bristol-Myers Squibb Company
Cyclic dinucleotides as anticancer agents

Last updated:

Abstract:

The present invention is directed to compounds of the formula ##STR00001## wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.

Status:
Grant
Type:

Utility

Filling date:

16 Oct 2018

Issue date:

30 Aug 2022